Effect of IL-13 on expression of IL-1β in acute renal ischemia/reperfusion injury in rats
Huijuan He
Abstract
Huijuan He
Abstract
AIM: To investigate the effects of IL-13 on expression of IL-1β in acute renal ischemia/reperfusion injury. METHODS: Fifty-seven male Wistar rats were randomly divided into 8 group: normal group,sham operation group, ischemia group, ischemia/reperfusion injury group(I/R), normal saline(NS)-treated group 1(C-1), NS-treated group 2(C-2),IL-13-treated group1(T-1)and IL-13-treated group 2(T-2).Rats were subjected to 45 min bilateral renal ischemia followed by reperfusion. rmIL-13 (1.5 μg/50 g body weight )was injected into the renal arteries through the abdominal aorta before ischemia(T-1) or immediately afterischemia(T-2).The serum level of IL-1β and the renal expression of IL-1β were determined in each group at 24 h post-ischemia. In addition, BUN,Cr and renal histology were also measured. RESULTS: (1)The serum level of IL-1β [C-1to T-1: (27.13±5.51) ng/L to (14.05±3.82) ng/L, P 0.01;C-2 to T-2: (29.52±5.84) ng/L to (14.27±3.52) ng/L, P 0.01], gene expression and protein production of IL-1β in kidney decreased markedly in IL-13-treated groups.(2)Renal function and histology were significantly improved in IL-13-treated groups, renal injury scores decreased significantly.(3)A positive correlation were found between the serum level of IL-1β and BUN,SCr( r= 0 708, P 0 01; r= 0 770, P 0 01).CONCLUSION: These data suggest that IL-13 inhibit the expression of IL-1β and improve function and histology of kidney in acute renal ischemia/reperfusion injury.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
AIM: To investigate the effects of IL-13 on expression of IL-1β in acute renal ischemia/reperfusion injury. METHODS: Fifty-seven male Wistar rats were randomly divided into 8 group: normal group,sham operation group, ischemia group, ischemia/reperfusion injury group(I/R), normal saline(NS)-treated group 1(C-1), NS-treated group 2(C-2),IL-13-treated group1(T-1)and IL-13-treated group 2(T-2).Rats were subjected to 45 min bilateral renal ischemia followed by reperfusion. rmIL-13 (1.5 μg/50 g body weight )was injected into the renal arteries through the abdominal aorta before ischemia(T-1) or immediately afterischemia(T-2).The serum level of IL-1β and the renal expression of IL-1β were determined in each group at 24 h post-ischemia. In addition, BUN,Cr and renal histology were also measured. RESULTS: (1)The serum level of IL-1β [C-1to T-1: (27.13±5.51) ng/L to (14.05±3.82) ng/L, P 0.01;C-2 to T-2: (29.52±5.84) ng/L to (14.27±3.52) ng/L, P 0.01], gene expression and protein production of IL-1β in kidney decreased markedly in IL-13-treated groups.(2)Renal function and histology were significantly improved in IL-13-treated groups, renal injury scores decreased significantly.(3)A positive correlation were found between the serum level of IL-1β and BUN,SCr( r= 0 708, P 0 01; r= 0 770, P 0 01).CONCLUSION: These data suggest that IL-13 inhibit the expression of IL-1β and improve function and histology of kidney in acute renal ischemia/reperfusion injury.
Key concepts: Medicine, Ischemia, Renal ischemia, Saline, Kidney, Internal medicine, Histology, Abdominal aorta